Brain and nerves Medicines Approved in the EU (EMA)

• 59medicines authorised in the EU (authorised now)

Each number has its full source under its own list below.

• 21Sep2026

  Nezglyal

  Active substance: leriglitazone

  EMEA/H/C/006693
• 19Jan2026

  Aqneursa

  Active substance: L-acetylleucine

  EMEA/H/C/006327
• 22Aug2024

  Tauvid

  Active substance: Flortaucipir (18F)

  EMEA/H/C/006064
• 7Dec2023

  Elucirem

  Active substance: Gadopiclenol

  EMEA/H/C/005626
• 7Dec2023

  Vueway

  Active substance: Gadopiclenol

  EMEA/H/C/006172
• 22Sep2023

  Tyruko

  Active substance: natalizumab

  EMEA/H/C/005752
• 26Jul2023

  Ztalmy

  Active substance: ganaxolone

  EMEA/H/C/005825
• 31May2023

  Lacosamide Adroiq

  Active substance: lacosamide

  EMEA/H/C/006047
• 18Aug2021

  Fingolimod Mylan

  Active substance: Fingolimod

  EMEA/H/C/005661
• 26Mar2021

  Ontozry

  Active substance: cenobamate

  EMEA/H/C/005377
• 18Dec2020

  Fintepla

  Active substance: fenfluramine hydrochloride

  EMEA/H/C/003933
• 16Nov2020

  Exparel liposomal

  Active substance: bupivacaine

  EMEA/H/C/004586
• 25Jun2020

  Fingolimod Accord

  Active substance: fingolimod hydrochloride 

  EMEA/H/C/005191
• 19Sep2019

  Epidyolex

  Active substance: cannabidiol

  EMEA/H/C/004675
• 26Aug2019

  Lacosamide UCB

  Active substance: lacosamide

  EMEA/H/C/005243

Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.

• Alzheimer's
• Pain
• Stroke
• Autoimmune diseases
• Oncology
• Mental health
• Cardiovascular
• Pediatric
• Sleep
• Infectious diseases